Skip to content

Study · Not a test of the peptide alone · 2024

2 results

Case report of a female western Indian vegetarian with obesity.

Niranjan V, Ozimek J

Obesity pillars1 Oct 2024

PMID39469669 (opens in a new tab)PMCIDPMC11513479 (opens in a new tab)DOI10.1016/j.obpill.2024.100137 (opens in a new tab)PepBankPUB-39469669
Read at sourcePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Semaglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Semaglutide.

  1. 01HumanNot a test of Semaglutide aloneCase report or seriesEfficacy outcome

    In a woman with obesity, a plan of lifestyle intervention, an Indian vegetarian meal plan and weekly semaglutide came with a 59 pound weight loss.

    In plain wordsIn one woman with obesity, a plan of diet, lifestyle changes and weekly semaglutide came with a 59 pound weight loss.

    Peptide
    Semaglutide
    Outcome
    DecreaseWeight loss
    Study

    n = 1

    Outcome group
    Body weight · Metabolic and weight

    Measurements

    Weight loss
    59 pounds
    patient

    Source sentences

    Summary
    The patient lost 59 pounds, and BMI changed from 34.1 kg/m2 to 23.5 kg/m2.
    2 context sentences
    Summary · context
    Intense lifestyle interventions including a custom-tailored Indian vegetarian meal plan and weekly injectable Semaglutide was offered to the patient as treatment plan.
    Summary · context
    In this case study of a South Asian patient, we present asynchronous co-management of obesity by an obesity specialist and the primary care provider in a university-based clinic.

    In this study, Semaglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Semaglutide.

  2. 02HumanNot a test of Semaglutide aloneCase report or seriesEfficacy outcome

    In a woman with obesity, the lifestyle and weekly semaglutide plan came with a BMI fall from 34.1 to 23.5 kg/m2.

    In plain wordsIn one woman with obesity, a plan of diet, lifestyle changes and weekly semaglutide came with a lower BMI.

    Peptide
    Semaglutide
    Outcome
    DecreaseBMI change
    Study

    n = 1

    Outcome group
    Body weight · Metabolic and weight

    Measurements

    BMI at start
    34.1 kg/m2
    patient
    BMI at end
    23.5 kg/m2
    patient

    Source sentences

    Summary
    The patient lost 59 pounds, and BMI changed from 34.1 kg/m2 to 23.5 kg/m2.
    2 context sentences
    Summary · context
    Intense lifestyle interventions including a custom-tailored Indian vegetarian meal plan and weekly injectable Semaglutide was offered to the patient as treatment plan.
    Summary · context
    In this case study of a South Asian patient, we present asynchronous co-management of obesity by an obesity specialist and the primary care provider in a university-based clinic.

    In this study, Semaglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Semaglutide.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:04 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:06 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.